Wednesday, March 19, 2025 | 01:31 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sharon Bio-Medicine reports standalone net loss of Rs 21.83 crore in the September 2017 quarter

Image

Capital Market

Sales decline 31.31% to Rs 24.57 crore

Net Loss of Sharon Bio-Medicine reported to Rs 21.83 crore in the quarter ended September 2017 as against net loss of Rs 153.77 crore during the previous quarter ended September 2016. Sales declined 31.31% to Rs 24.57 crore in the quarter ended September 2017 as against Rs 35.77 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales24.5735.77 -31 OPM %-67.60-392.20 -PBDT-4.64-176.05 97 PBT-5.88-181.06 97 NP-21.83-153.77 86

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 09 2017 | 5:26 PM IST

Explore News